BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36127155)

  • 1. Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership.
    Lynch C; Harrison S; Emery JD; Clelland C; Dorman L; Collins C; Johansen ML; Lawrenson R; Surgey A; Weller D; Jarbøl DE; Balasubramaniam K; Nicholson BD
    Br J Gen Pract; 2023 Feb; 73(727):e88-e94. PubMed ID: 36127155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations and referral for suspected cancer in primary care in New Zealand-A survey linked to the International Cancer Benchmarking Partnership.
    Htun HW; Elwood JM; Ioannides SJ; Fishman T; Lawrenson R
    Eur J Cancer Care (Engl); 2017 May; 26(3):. PubMed ID: 28105767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
    Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
    BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership.
    Lynch C; Harrison S; Butler J; Baldwin DR; Dawkins P; van der Horst J; Jakobsen E; McAleese J; McWilliams A; Redmond K; Swaminath A; Finley CJ
    Cancer Control; 2022; 29():10732748221119354. PubMed ID: 36269109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).
    Menon U; Weller D; Falborg AZ; Jensen H; Butler J; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Fourkala EO; Gavin AT; Grunfeld E; Harland E; Kalsi J; Law RJ; Lin Y; Turner D; Neal RD; White V; Harrison S; Reguilon I; Lynch C; Vedsted P;
    Br J Cancer; 2022 Sep; 127(5):844-854. PubMed ID: 35618787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
    Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
    BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data.
    Vedsted P; Weller D; Zalounina Falborg A; Jensen H; Kalsi J; Brewster D; Lin Y; Gavin A; Barisic A; Grunfeld E; Lambe M; Malmberg M; Turner D; Harland E; Hawryluk B; Law RJ; Neal RD; White V; Bergin R; Harrison S; Menon U; ;
    BMJ Open; 2022 Dec; 12(12):e059669. PubMed ID: 36521881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).
    Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D
    BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study.
    Lynch C; Reguilon I; Langer DL; Lane D; De P; Wong WL; Mckiddie F; Ross A; Shack L; Win T; Marshall C; Revheim ME; Danckert B; Butler J; Dizdarevic S; Louzado C; Mcgivern C; Hazlett A; Chew C; O'connell M; Harrison S
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33306102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of Leadership in Facilitating Change to Improve Cancer Survival: An Analysis of Experiences in Seven High Income Countries in the International Cancer Benchmarking Partnership (ICBP).
    Morris M; Seguin M; Landon S; McKee M; Nolte E
    Int J Health Policy Manag; 2022 Sep; 11(9):1756-1766. PubMed ID: 34380203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International variation in adherence to referral guidelines for suspected cancer: a secondary analysis of survey data.
    Nicholson BD; Mant D; Neal RD; Hart N; Hamilton W; Shinkins B; Rubin G; Rose PW
    Br J Gen Pract; 2016 Feb; 66(643):e106-13. PubMed ID: 26740607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.
    Eden M; Harrison S; Griffin M; Lambe M; Pettersson D; Gavin A; Brewster DH; Lin Y; Johannesen TB; Milne RL; Farrugia H; Nishri D; King MJ; Huws DW; Warlow J; Turner D; Earle CC; Peake M; Rashbass J
    Cancer Epidemiol; 2019 Feb; 58():184-192. PubMed ID: 30639877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2.
    Andersson TM; Myklebust TÅ; Rutherford MJ; Møller B; Arnold M; Soerjomataram I; Bray F; Parkin DM; Lambert PC
    Br J Cancer; 2022 May; 126(8):1224-1228. PubMed ID: 35058590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced-stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross-sectional study.
    Tørring ML; Falborg AZ; Jensen H; Neal RD; Weller D; Reguilon I; ; Menon U; Vedsted P
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13100. PubMed ID: 31119836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "There's Not Enough Bodies to Do the Demand": An Exploration of Key Stakeholder Views on the Role of Health Service Capacity in Shaping Cancer Outcomes in 7 International Cancer Benchmarking Partnership Countries.
    Seguin M; Morris M; McKee M; Nolte E
    Int J Health Policy Manag; 2022 Jul; 11(7):1024-1034. PubMed ID: 33589567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying important health system factors that influence primary care practitioners' referrals for cancer suspicion: a European cross-sectional survey.
    Harris M; Vedsted P; Esteva M; Murchie P; Aubin-Auger I; Azuri J; Brekke M; Buczkowski K; Buono N; Costiug E; Dinant GJ; Foreva G; Gašparović Babić S; Hoffman R; Jakob E; Koskela TH; Marzo-Castillejo M; Neves AL; Petek D; Petek Ster M; Sawicka-Powierza J; Schneider A; Smyrnakis E; Streit S; Thulesius H; Weltermann B; Taylor G
    BMJ Open; 2018 Sep; 8(9):e022904. PubMed ID: 30185577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data.
    Rubin GP; Saunders CL; Abel GA; McPhail S; Lyratzopoulos G; Neal RD
    Br J Cancer; 2015 Feb; 112(4):676-87. PubMed ID: 25602963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.